🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pascal Hammel

Université Paris-Saclay

ORCID: 0000-0002-4630-4996

Also affiliated with Délégation Ile-de-France Villejuif, Assistance Publique – Hôpitaux de Paris, Laboratoire d'études sur les monothéismes, Hôpital Paul-Brousse

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer”.

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Journal of Clinical Oncology(2022)10.1200/jco.21.01604
N/A
4.0DataRank · unranked
230 citations

Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall +14 more

Management recommendations for pancreatic manifestations of von Hippel–Lindau disease

Cancer(2021)10.1002/cncr.33978
N/A
0DataRank · unranked
51 citations

Rachel van Leeuwaarde, Dhaval Patel, Xavier M. Keutgen, Pascal Hammel, Naris Nilubol +5 more

Activation of lysosomal iron triggers ferroptosis in cancer

Research Square(2024)10.21203/rs.3.rs-4165774/v1
N/A
0DataRank · unranked
16 citations

Tatiana Cañeque, Leeroy Baron, Sebastian Müller, Alanis Carmona, Ludovic Colombeau +29 more